Algernon Pharmaceuticals's market cap is currently $1.18M. The company's EPS TTM is $-0.025; its P/E ratio is ―; Algernon Pharmaceuticals is scheduled to report earnings on January 23, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Sep 22	Sep 21	Sep 20	Sep 19
Income Statement
Total Revenue	C$ 0.00	C$ 0.00	C$ 0.00	C$ 0.00	C$ 0.00
Gross Profit	C$ -50.40K	C$ -34.94K	C$ 0.00	C$ 0.00	C$ -27.00K
Operating Income	C$ -5.02M	C$ -6.06M	C$ -8.05M	C$ -8.76M	C$ -1.93M
EBITDA	C$ -4.98M	C$ -6.02M	C$ 0.00	C$ -8.54M	C$ -1.87M
Net Income	C$ -6.78M	C$ -6.05M	C$ -7.72M	C$ -8.42M	C$ -1.88M
Balance Sheet
Cash & Short-Term Investments	C$ 125.08K	C$ 1.41M	C$ 2.41M	C$ 6.12M	C$ 207.81K
Total Assets	C$ 4.19M	C$ 8.14M	C$ 10.14M	C$ 12.82M	C$ 5.34M
Total Debt	C$ 0.00	C$ 0.00	C$ 0.00	C$ 0.00	C$ 0.00
Net Debt	C$ -125.08K	C$ -1.41M	C$ -2.41M	C$ -6.12M	C$ -207.81K
Total Liabilities	C$ 2.72M	C$ 2.52M	C$ 1.02M	C$ 607.05K	C$ 365.46K
Stockholders' Equity	C$ 1.47M	C$ 5.62M	C$ 9.12M	C$ 12.22M	C$ 4.97M
Cash Flow
Free Cash Flow	C$ -2.61M	C$ -3.06M	C$ -7.95M	C$ -6.71M	C$ -1.85M
Operating Cash Flow	C$ -2.55M	C$ -2.91M	C$ -7.82M	C$ -6.61M	C$ -1.78M
Investing Cash Flow	C$ -59.50K	C$ -144.61K	C$ -124.45K	C$ -99.74K	C$ 90.18K
Financing Cash Flow	C$ 1.33M	C$ 2.06M	C$ 4.25M	C$ 12.62M	C$ 647.99K

Currency in CAD

Algernon Pharmaceuticals Earnings and Revenue History

Income Statement >

Algernon Pharmaceuticals Debt to Assets

Balance Sheet >

Algernon Pharmaceuticals Cash Flow

Cash Flow >

Algernon Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing